Orphan Medical, Inc. (ORPH)
Article Abstract:
The operations and management of Orphan Medical Inc of Minnetonka, MN, are discussed in detail by CEO John Howell Bullion. Orphan Medical develops drugs for diseases that are rarely or not adequately treated.
Publisher: Wall Street Transcript Corporation
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
Bullion, John Howell, Orphan Medical Inc.
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
InterMune Pharmaceuticals, Inc. (TMM)
Article Abstract:
The operations and management of InterMune Pharmaceuticals Inc of Brisbane, CA, are discussed in detail by CEO W. Scott Harkonen. The company develops pulmonary and infectious disease treatments.
Publisher: Wall Street Transcript Corporation
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
Harkonen, W. Scott, InterMune Pharmaceuticals Inc.
Publication Name: The Wall Street Transcript
Subject: Business
ISSN: 0043-0102
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Management, Pharmaceutical industry, Drugs, Interview, Company Profile
Similar abstracts:
- Abstracts: NexMed, Inc. (NEXM). Peregrine Pharmaceutics, Inc. (PPHM). Cell Pathways, Inc. (CLPA)
- Abstracts: Forbes Medi-Tech Inc. (FMTI). Vion Pharmaceuticals, Inc. (VION). AnorMED Inc. (AOM.TO)
- Abstracts: Divserified Senior Services, Inc. (DISS). Tender Loving Care Health Care Services, Inc. (TLCS)
- Abstracts: Hemispherx BioPharma (HEB). DrugAbuse Sciences, Inc. AtheroGenics, Inc. (AGIX)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.